NICE gives go ahead to intrabeam radiotherapy for breast cancerBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4863 (Published 29 July 2014) Cite this as: BMJ 2014;349:g4863
- Helen Mooney
Intrabeam radiotherapy, a single dose treatment used during surgery for patients with breast cancer, has been given the go ahead for use in the NHS in England.
The National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that the treatment should be considered for people with early stage breast cancer.1 Intrabeam radiotherapy can be given as a single dose radiotherapy during breast cancer surgery and would eliminate the need for patients to make additional trips to hospital for treatment.
Carole Longson, NICE’s director of health …
Log in using your username and password
Log in through your institution
Sign up for a free trial